Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
暂无分享,去创建一个
B. Giusti | A. Gori | R. Abbate | G. Gensini | R. Marcucci | D. Antoniucci | S. Valente | R. Paniccia | C. Saracini | I. Sestini